Join our daily newsletter At The Bell to receive exclusive market insights
- Creso Pharma’s (CPH) subsidiary in Canada has secured C$742,572 (A$808,572) worth of orders for its cannabis products
- Mernova Medicinal reports the bulk of the sales are from partners Cannabis NB, Nova Scotia and Yukon Liquor Corps and Ontario Cannabis Retail Corporation
- CPH says the repeat orders from the partners are a testament to the quality of Mernova’s indoor grown product range
- The company is in discussion with the partners to expand the supplied product range after Mernova created 14 new strains
- Shares in Creso Pharma are 2.38 per cent 10.8 cents each at 12:43 pm AEDT
Creso Pharma’s (CPH) subsidiary in Canada has secured orders worth C$742,572 (A$808,572) for its cannabis products.
Mernova Medicinal is a licensed cultivation producer based in Nova Scotia and is 100 per cent owned by CPH.
The company reports the bulk of today’s sales are from partners, with C$535,533 (A$583,261) in repeat purchase orders received.
Among the partners ordering from Mernova are Cannabis NB, Nova Scotia Liquor Corporation, Yukon Liquor Corporation and Ontario Cannabis Retail Corporation.
Creso said the repeat orders from the partners was a testament to the quality of Mernova’s indoor grown product range.
Mernova’s Managing Director Jack Yu said he was very pleased with the lastest round of orders.
“Recent purchase orders from both provincial partners and bulk suppliers highlight the traction we are generating in the Canadian market,” Mr Yu said.
“We continue to receive very good customer feedback on our range of dried flower and pre-roll joint products, which is leading to consumer uptake.”
The company is in discussion with its partners to expand the supplied product range after Mernova created 14 new strains.
“Work to introduce new strains, innovative products and grow our footprint in Canada is ongoing and I am confident that Mernova will continue to generate sales growth,” Mr Yu said.
Shares in Creso Pharma were trading up 2.38 per cent at 10.8 cents per share at 12:43 pm AEDT.
